This page does not exist in your selected language. Your preference was saved and you will be notified once a page can be viewed in your language.
This page is also available in your prefered language. Switch to that version.
Confidently address increasing demands for enhanced quality, efficiency, accuracy, compliance, and production with instrumentation, intuitive software, hands-on training, and comprehensive services for the biopharmaceutical, chemical, food and beverage industries, and academic sector.
Experience quick start-up and streamline workflows with our product and platform solutions ideally suited to meet your laboratory and bioprocess application needs. From consumables and laboratory water purification systems to industry-leading weighing technology, our sophisticated solutions also include liquid handling, fermentation, filtration, and fluid management.
Find out how to accelerate clinical pipelines, increase drug manufacturing efficiency, and reduce costs with our bioprocess solutions.
Find deals and special offers on Sartorius lab and bioprocessing products and services
Your opportunity to experience Sartorius solutions for your specific bioprocess as well as laboratory tasks and applications.
Proper life cycle management starts with the proper installation of equipment and basic user training.
We make it our priority to provide products that ensure the highest level of confidence – test after test.
Sartorius, through its French listed subgroup Sartorius Stedim Biotech, successfully acquired Polyplus in July 2023. The French company is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are key components in the manufacture of viral vectors.
Sartorius, through its subgroup Sartorius Stedim Biotech, acquired Albumedix in 2022. The company provides recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications, for example as an animal-free additive to cell culture media and for the stabilization of vaccines and viral therapies.
Sartorius, through its French listed subgroup Sartorius Stedim Biotech, acquired the Novasep chromatography division in 2022. The unit comprises resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure, multi-use applications for smaller molecules, such as oligonucleotides, peptides and insulin.
Sartorius expanded its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH in January 2022. The laboratory technology company develops, manufactures and markets solutions for the automated analysis, selection and isolation of cells. Other application areas are the development of cell and gene therapeutics as well as rare single cell molecular diagnostics in cancer and prenatal research.
Sartorius, through its subgroup Sartorius Stedim Biotech, acquired cell culture specialist Xell AG in July 2021. Xell develops, produces, and markets media and feed supplements for cell cultures, especially for manufacturing viral vectors that are used in gene therapeutics and vaccines. Beyond these media, the company offers various analytical services for characterizing, screening, and quantifying media components, as well as for optimizing media composition.
Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH in 2021. The company produces and markets cell culture components, such as growth factors, cytokines and media in GMP quality for manufacturing cell and gene therapy products.
Sartorius, through its subgroup Sartorius Stedim Biotech, acquired purification expert WaterSep BioSeparations in 2020. WaterSep BioSeparations develops, manufactures and markets hollow‑fiber membrane devices and pre-sterilized assemblies for upstream and downstream biopharmaceutical applications.
Sartorius, through its subgroup Sartorius Stedim Biotech, successfully closed the acquisition of the Slovenian purification specialist BIA Separations in November 2020. BIA Separations develops and manufactures market-leading products for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are used in cell and gene therapies and other advanced therapies.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now